Blackstone, Novo Nordisk A/S, BlackRock, SpringWorks Therapeutics, and Apollo Global Management are the five Growth stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Growth stocks within the last several days.
Blackstone (BX)
Blackstone Inc. is an alternative asset management firm specializing in real estate, private equity, hedge fund solutions, credit, secondary funds of funds, public debt and equity and multi-asset class strategies. The firm typically invests in early-stage companies. It also provide capital markets services.
Shares of BX traded down $1.75 on Friday, hitting $132.80. The company's stock had a trading volume of 4,663,070 shares, compared to its average volume of 3,760,752. The firm has a market capitalization of $96.87 billion, a price-to-earnings ratio of 36.58, a P/E/G ratio of 1.07 and a beta of 1.61. The company has a quick ratio of 0.71, a current ratio of 0.67 and a debt-to-equity ratio of 0.61. Blackstone has a fifty-two week low of $115.66 and a fifty-two week high of $200.96. The firm's fifty day moving average price is $141.56 and its 200-day moving average price is $163.98.
Read Our Latest Research Report on BX
Novo Nordisk A/S (NVO)
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease.
Shares of NVO traded down $0.56 during trading hours on Friday, reaching $62.07. The stock had a trading volume of 7,826,465 shares, compared to its average volume of 6,098,529. Novo Nordisk A/S has a 12 month low of $57.00 and a 12 month high of $148.15. The company's 50-day moving average is $73.62 and its two-hundred day moving average is $89.80. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.55 and a current ratio of 0.74. The stock has a market capitalization of $278.54 billion, a PE ratio of 18.87, a PEG ratio of 0.90 and a beta of 0.61.
Read Our Latest Research Report on NVO
BlackRock (BLK)
BlackRock, Inc. is a publicly owned investment manager. The firm primarily provides its services to institutional, intermediary, and individual investors including corporate, public, union, and industry pension plans, insurance companies, third-party mutual funds, endowments, public institutions, governments, foundations, charities, sovereign wealth funds, corporations, official institutions, and banks.
NYSE BLK traded down $7.98 during trading hours on Friday, reaching $908.28. The company's stock had a trading volume of 444,438 shares, compared to its average volume of 684,264. The stock has a market cap of $141.01 billion, a P/E ratio of 21.63, a P/E/G ratio of 1.90 and a beta of 1.38. BlackRock has a 52 week low of $748.78 and a 52 week high of $1,084.22. The firm has a fifty day simple moving average of $922.02 and a 200-day simple moving average of $983.49. The company has a debt-to-equity ratio of 0.45, a current ratio of 5.23 and a quick ratio of 5.23.
Read Our Latest Research Report on BLK
SpringWorks Therapeutics (SWTX)
SpringWorks Therapeutics, Inc., a commercial-stage biopharmaceutical company, engages in the development and commercialization of medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is OGSIVEO (nirogacestat), an oral small molecule gamma secretase inhibitor that is in Phase III DeFi trial for the treatment of desmoid tumors; and Nirogacestat, is also in Phase 2 clinical development as a monotherapy for the treatment of ovarian granulosa cell tumors (GCT), a subtype of ovarian cancer.
Shares of NASDAQ SWTX traded down $0.21 during trading on Friday, reaching $44.72. The company had a trading volume of 7,805,636 shares, compared to its average volume of 1,467,102. The company's fifty day moving average price is $46.20 and its 200-day moving average price is $40.50. The stock has a market cap of $3.35 billion, a P/E ratio of -12.85 and a beta of 0.79. SpringWorks Therapeutics has a 12 month low of $28.21 and a 12 month high of $62.00.
Read Our Latest Research Report on SWTX
Apollo Global Management (APO)
Apollo Global Management, Inc. is a private equity firm specializing in investments in credit, private equity, infrastructure, secondaries and real estate markets. The firm prefers to invest in private and public markets. The firm's private equity investments include traditional buyouts, recapitalization, distressed buyouts and debt investments in real estate, corporate partner buyouts, distressed asset, corporate carve-outs, middle market, growth, venture capital, turnaround, bridge, corporate restructuring, special situation, acquisition, and industry consolidation transactions.
Apollo Global Management stock traded up $0.21 during mid-day trading on Friday, hitting $133.53. 2,588,258 shares of the stock were exchanged, compared to its average volume of 3,823,214. The firm's fifty day simple moving average is $134.70 and its two-hundred day simple moving average is $153.02. The company has a quick ratio of 1.44, a current ratio of 1.44 and a debt-to-equity ratio of 0.33. Apollo Global Management has a 12 month low of $95.11 and a 12 month high of $189.49. The stock has a market capitalization of $76.18 billion, a price-to-earnings ratio of 18.27, a PEG ratio of 1.17 and a beta of 1.66.
Read Our Latest Research Report on APO
Further Reading
Before you consider Blackstone, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Blackstone wasn't on the list.
While Blackstone currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
